Day: February 23, 2026

Apple Market Store FrontWith fas craves and fas REWARDSFood and BeveragesSelection of Grab-n-Go food and dispensed beveragesStore InteriorWide array of convenient product offeringsFriendly StaffEmployees are ready to helpFresh Grab-n-GoHealthy pre-packaged optionsCheckout CounterIncluding candy and nicotine productsRICHMOND, Va., Feb. 23, 2026 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO), a Fortune 500 company and one of the largest convenience store operators in the United States, proudly announces the opening of the newly remodeled Apple Market with the fas craves food concept, located at 108 East Main Street, Hazard, KY 41701. This store represents the fourth fas craves remodel, following two earlier new‑to‑industry openings, bringing the total number of fas crave locations...

SAN CLEMENTE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Raymond James 47th Annual Institutional Investors Conference on March 2, 2026 Company management will present at the Raymond James 47th Annual Institutional Investors Conference in Orlando, FL on Monday, March 2, 2026. The presentation will begin at 11:15 a.m. PT (2:15 p.m. ET). KeyBanc Healthcare Forum on March 18, 2026 Company management will participate in a fireside chat at the KeyBanc Healthcare Forum, held virtually on Wednesday, March 18, 2026. The discussion will begin at 10:30 a.m. PT (1:30 p.m. ET). 25th Annual Needham Virtual Healthcare Conference on April 13, 2026 Company management...

Regulatory Shift Could Significantly Lower Phase 3 Costs and Accelerate Path Toward NDA Submission for AD04 GLEN ALLEN, Va., Feb. 23, 2026 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today highlighted recent U.S. Food and Drug Administration (FDA) policy direction described by FDA Commissioner Martin A. Makary, M.D., M.P.H., and Vinay Prasad, M.D., M.P.H., in a commentary published February 19, 2026, in The New England Journal of Medicine. In the article, FDA leadership outlined a shift in the agency’s default evidentiary posture under which, where scientifically appropriate, approval may be supported by one adequate and well-controlled clinical...

BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) — Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that company leadership will participate in multiple upcoming investor conferences. Ryan Cohlhepp, Pharm.D., President and Chief Operating Officer at Bicara will take part in fireside chats at:TD Cowen 46th Annual Health Care ConferenceDate and Time: Monday, March 2, 1:10-1:40 p.m. ET in BostonBarclays 28th Annual Global Healthcare ConferenceDate and Time: Tuesday, March 10, 11:30-11:55 a.m. ET in Miami Bicara management will also attend the 2026 Jefferies Biotech on the Beach Summit, taking place March 10-11 in Miami. Live webcasts of the fireside chats will be accessible through the Investor...

New board nominees Glenda Dorchak, Eliot Pence, Michelle Reynolds, and The Hon. Heidi Shyu, in addition to Christian Weedbrook and Bill Fradin, bring deep experience across global corporate leadership, public markets and finance, operations, and defense and technology.TORONTO, Feb. 23, 2026 (GLOBE NEWSWIRE) — Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum computing company, and Crane Harbor Acquisition Corp. (“Crane Harbor”) (Nasdaq: CHAC), a publicly traded special purpose acquisition company, today announced the proposed nomination of:Glenda Dorchak, former public company Chief Executive Officer and Chairman of several companies and current board member of GlobalFoundries and Cerebras; Eliot Pence, Founder of Dominion Dynamics and former global growth leader at Anduril Industries; Michelle Reynolds,...

Multiple new federal actions highlight deep brain neurostimulation as a high-priority emerging therapy for TBI, PTSD, stroke recovery, and Alzheimer’s disease HOUSTON, TX, Feb. 23, 2026 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), developer of Deep Intracranial Frequency Stimulation (DIFS™) technology for non-invasive deep brain stimulation, commended the recent series of bipartisan Congressional initiatives expanding federal focus on deep brain neurostimulation and related neuromodulation research within the U.S. Department of Veterans Affairs (“VA”) and the National Institutes of Health (“NIH”). Nexalin’s team participated in and helped shape specific portions of the legislation to expand veterans’ access to emerging treatments, and commends Congress on the recent passage of appropriations...

MONROE TOWNSHIP, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NYSE American: OPTT) today provided an operational update highlighting continued global deployments and progress on its offshore autonomy infrastructure roadmap. The Company has shipped a WAM-V®, autonomous surface vehicle to Greece to support ongoing customer operations and field activity in the region. This deployment expands OPT’s international operational footprint and reflects continued engagement across defense and commercial maritime markets. In parallel, OPT has transitioned its integrated docking and charging program from prototype to a full-scale build, including autonomous docking and redeployment. The Company has placed orders for components to support system integration and open-water validation as it advances...

TOKYO, Feb. 23, 2026 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE” or the “Company”), a Japanese real estate developer of luxury residential properties, including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, and which develops and operates the ENT TERRACE brand of extended-stay hotels, today announced the completion of its single-family home project, Naoi Style Nakameguro Yutenji 1-Chome, located in Meguro-ku, Tokyo. As previously disclosed, construction of the property commenced in February 2025. The property has received its completion certificate (Certificate No. JE25BC1-13-0473) and has begun marketing activities for the property.Exterior of Naoi Style Nakameguro Yutenji 1-Chome Naoi Style Nakameguro Yutenji 1-Chome is a three-story wooden...